Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 3/20 | 0.56 |
| ▸ | TACR1 | P25103 | 2/20 | 0.56 |
| ▸ | CTRB1 | P17538 | 2/20 | 0.55 |
| ▸ | CTSS | P25774 | 2/20 | 0.54 |
| ▸ | CTSL | P07711 | 1/20 | 0.54 |
| ▸ | CTSB | P07858 | 1/20 | 0.54 |
| ▸ | IDO1 | P14902 | 1/20 | 0.54 |
| ▸ | CASP1 | P29466 | 3/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
| ▸ | ITGB3 | P05106 | 4/20 | 0.53 |
| ▸ | ITGA2B | P08514 | 4/20 | 0.53 |
| ▸ | KYNU | Q16719 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29017554 | 1.00 | CTSK (0.56) | CTSKTACR1CTRB1CTSSCTSL | |
| SCHEMBL29521405 | 1.00 | CTSK (0.56) | CTSKTACR1CTRB1CTSSCTSL | |
| Hydrochloric Acid SCHEMBL6933213 | 0.98 | CTSK (0.54) | CTSKTACR1CTRB1CTSSCTSL | |
| Hydrochloric Acid SCHEMBL28683702 | 0.98 | CTSK (0.54) | CTSKTACR1CTRB1CTSSCTSL | |
| SCHEMBL8354112 | 0.91 | CTSK (0.54) | CTSKTACR1CTSSCTSLCTSB | |
| SCHEMBL2959219 | 0.91 | CTSK (0.54) | CTSKTACR1CTSSCTSLCTSB | |
| SCHEMBL2959221 | 0.91 | CTSK (0.54) | CTSKTACR1CTSSCTSLCTSB | |
| SCHEMBL4346138 | 0.91 | KYNU (0.63) | CTSKTACR1CTRB1CTSSCTSL | |
| SCHEMBL2115471 | 0.91 | KYNU (0.63) | CTSKTACR1CTRB1CTSSCTSL | |
| SCHEMBL3258258 | 0.91 | KYNU (0.63) | CTSKTACR1CTRB1CTSSCTSL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240116985-A1 | STAPLED PEPTIDES AND METHODS THEREOF | PARABILIS MEDICINES, INC. | 2024-04-11 | — | — | US | disclosed |
| US-20230271917-A1 | AMINO ACIDS | PARABILIS MEDICINES, INC. | 2023-08-31 | — | — | US | disclosed |
| EP-4185284-A1 | AMINO ACIDS | Fog Pharmaceuticals, Inc. (US) | 2023-05-31 | — | — | EP | disclosed |
| CN-116113621-A | Amino acids | 弗格制药有限公司 | 2023-05-12 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240116985-A1 | STAPLED PEPTIDES AND METHODS THEREOF | CTNNB1, APC, CTNNA1 | CTSK 2053/4885TACR1 3784/4885CTRB1 2805/4885 |
| US-20230271917-A1 | AMINO ACIDS | NPPA, QPCTL, PTMS | CTSK 1914/4885TACR1 1215/4885CTRB1 4185/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.